Annette West, PA
Physician Assistant · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 3
Offices
3 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Annette West’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$20,410
Medicare paid this office $20,410 for 62 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, testosterone undecanoate, 1 mg | 12 | $13,381 | None |
| Return visit (30+ min) | 34 | $3,616 | $100 |
| Injection of drug or substance under skin or into muscle | 16 | $207 | $12 |
| Ultrasound measurement of bladder capacity after voiding | 17 | $187 | $11 |
Who their Medicare patients are
62 Original Medicare patients in 2024. Average age 77 · Health risk score 1.00. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Diabetes 34% · Cancer 34% · Atrial fibrillation 31% · Chronic kidney disease 29% · Heart failure 21%.
The office billed $88,495, Medicare allowed $25,914 and paid $20,410; for 9,930 services of 18 kinds; $13,447 of it was for drugs given in the office and $6,962 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 62 | 9,930 | 77 | 1.00 | $88,495 | $20,410 |
| 2015 | 30 | 31 | 75 | 5.47 | $8,485 | $1,854 |
| 2014 | 141 | 166 | 75 | 3.23 | $56,205 | $11,785 |
| 2013 | 111 | 129 | 74 | 3.95 | $57,779 | $9,653 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2014: 5 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 43 | $3,262 | $76 |
| Short return visit (20+ min) | 21 | $1,447 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,100 | $79 |
| Return visit (30+ min) | 16 | $1,070 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $708 | $54 |
2013: 3 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 33 | $2,413 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $1,821 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,330 | $53 |
Drugs they prescribed that Part D paid
$75,964
Pharmacies billed $75,964 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 10% of their Part D prescriptions (52 of 538) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
496 generic and 42 brand-name prescriptions · $75,964 in drug cost · 200 antibiotic prescriptions to 154 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Testosterone | 99 | $39,148 | $395 |
| Xyosted | 15 | $16,023 | $1,068 |
| Testosterone Cypionate | 80 | $3,792 | $47 |
| Tamsulosin | 32 | $507 | $16 |
| Levofloxacin | 86 | $488 | $6 |
See all 9 drugs
| Testosterone | 99 | $39,148 | $395 |
| Xyosted | 15 | $16,023 | $1,068 |
| Testosterone Cypionate | 80 | $3,792 | $47 |
| Tamsulosin | 32 | $507 | $16 |
| Levofloxacin | 86 | $488 | $6 |
| Oxycodone-Acetaminophen | 51 | $485 | $10 |
| Sulfamethoxazole-Trimethoprim | 97 | $443 | $5 |
| Meloxicam | 27 | $93 | $3 |
| Cephalexin | 15 | $65 | $4 |
Year by year
| 2024 | 538 | 230 | 10% (52) | 8% | $75,964 |
| 2023 | 391 | 157 | 9% (36) | 6% | $53,015 |
| 2022 | 13 | None | None | None | $1,349 |
| 2014 | 17 | None | None | 0% | $275 |
| 2013 | 15 | 11 | None | None | $133 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Testosterone | 89 | $30,646 | $344 |
| Xyosted | 12 | $8,787 | $732 |
| Testosterone Cypionate | 48 | $2,423 | $50 |
| Dutasteride | 11 | $513 | $47 |
| Tamsulosin | 42 | $431 | $10 |
| Sulfamethoxazole-Trimethoprim | 35 | $372 | $11 |
| Levofloxacin | 47 | $307 | $7 |
| Oxycodone-Acetaminophen | 20 | $220 | $11 |
| Hydrocodone-Acetaminophen | 16 | $157 | $10 |
| Meloxicam | 27 | $92 | $3 |
Money from drug and device companies
$1,494 in 2025
| 2025 | 9 | 66 | None | $1,494 |
| 2024 | 12 | 62 | None | $3,201 |
| 2023 | 16 | 65 | None | $2,061 |
| 2022 | 7 | 19 | None | $963 |
| 2021 | 4 | 7 | None | $288 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Coloplast | Titan | $596 | 9 payments
|
| Antares Pharma | Xyosted | $433 | 40 payments
|
| Boston Scientific | Obsidio | $150 | 5 payments
|
| Sumitomo Pharma America | Gemtesa | $128 | 4 payments
|
| Progenics Pharmaceuticals | Pylarify | $47 | 2 payments
|
| Endo USA | Aveed | $42 | 2 payments
|
See all 66 published payments
| Antares Pharma | Meals · 2025-12-17 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-12-17 | Xyosted | $21 |
| Verity Pharmaceuticals | Meals · 2025-12-16 | Tlando | $20 |
| Sumitomo Pharma America | Meals · 2025-12-04 | Gemtesa | $39 |
| Antares Pharma | Meals · 2025-12-03 | Xyosted | $23 |
| Antares Pharma | Meals · 2025-12-03 | Xyosted | $1 |
| Coloplast | Meals · 2025-12-02 | Titan | $172 |
| Procept Biorobotics | Meals · 2025-11-25 | Aquabeam Robotic System | $21 |
| Antares Pharma | Meals · 2025-11-19 | Xyosted | $1 |
| Antares Pharma | Meals · 2025-11-19 | Xyosted | $20 |
| Coloplast | Meals · 2025-11-17 | Titan | $34 |
| Blue Earth Diagnostics | Meals · 2025-11-14 | Posluma | $37 |
| Coloplast | Meals · 2025-10-30 | Titan | $140 |
| Coloplast | Meals · 2025-10-29 | Titan | $24 |
| Antares Pharma | Meals · 2025-10-29 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-10-29 | Xyosted | $19 |
| Coloplast | Meals · 2025-10-18 | Titan | $2 |
| Antares Pharma | Meals · 2025-10-15 | Xyosted | $1 |
| Antares Pharma | Meals · 2025-10-15 | Xyosted | $20 |
| Antares Pharma | Meals · 2025-09-24 | Xyosted | $21 |
| Coloplast | Meals · 2025-09-10 | Titan | $101 |
| Coloplast | Meals · 2025-09-10 | Titan | $76 |
| Antares Pharma | Meals · 2025-09-10 | Xyosted | $20 |
| Antares Pharma | Meals · 2025-09-10 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-08-27 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-08-27 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-08-13 | Xyosted | $14 |
| Antares Pharma | Meals · 2025-08-13 | Xyosted | $3 |
| Verity Pharmaceuticals | Meals · 2025-08-11 | Tlando | $20 |
| Boston Scientific | Meals · 2025-08-06 | Obsidio | $21 |
| Antares Pharma | Meals · 2025-07-30 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-07-30 | Xyosted | $17 |
| Progenics Pharmaceuticals | Meals · 2025-07-10 | Pylarify | $22 |
| Antares Pharma | Meals · 2025-07-09 | Xyosted | $17 |
| Sumitomo Pharma America | Meals · 2025-06-20 | Gemtesa | $29 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $18 |
| Progenics Pharmaceuticals | Meals · 2025-05-29 | Pylarify | $24 |
| Boston Scientific | Meals · 2025-05-28 | Obsidio | $40 |
| Sumitomo Pharma America | Meals · 2025-05-21 | Gemtesa | $21 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $3 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $15 |
| Boston Scientific | Meals · 2025-05-14 | General - Structural Heart | $30 |
| Sumitomo Pharma America | Meals · 2025-05-08 | Gemtesa | $39 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $17 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $16 |
| Endo USA | Meals · 2025-04-02 | Xiaflex | $18 |
| Coloplast | Meals · 2025-03-31 | Titan | $4 |
| Coloplast | Meals · 2025-03-31 | Titan | $44 |
| Boston Scientific | Meals · 2025-03-29 | Avvigo Guidance System | $24 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $16 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-03-12 | Xyosted | $16 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $15 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $2 |
| Boston Scientific | Meals · 2025-02-13 | Axonics | $36 |
| Antares Pharma | Meals · 2025-02-05 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $18 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $2 |
| Endo USA | Meals · 2025-01-15 | Aveed | $24 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $18 |
See earlier years (2024, 2023, 2022, 2021)
2024: $3,201
| Axonics | Axonics | $1,736 | 13 payments
|
| Antares Pharma | Xyosted | $431 | 31 payments
|
| Boston Scientific | Watchman Flx | $323 | 8 payments
|
| Coloplast | Titan | $219 | 2 payments
|
| Medtronic | Interstim | $164 | 1 payment
|
| Endo Pharmaceuticals | Xiaflex | $108 | 1 payment
|
| Innovation Technologies | Irrisept | $84 | 1 payment
|
| Astellas Pharma US | Xtandi | $38 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $34 | 1 payment
|
| Urogen Pharma | Jelmyto | $26 | 1 payment
|
| Pfizer | Xtandi | $21 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $17 | 1 payment
|
2023: $2,061
| Coloplast | Titan | $669 | 12 payments
|
| Antares Pharma | Nocdurna | $354 | 13 payments
|
| Supernus Pharmaceuticals | Xyosted | $295 | 22 payments
|
| Axonics | Bulkamid | $223 | 3 payments
|
| Edap Technomed | None | $125 | 1 payment
|
| Abbott Laboratories | Ensite Precision | $96 | 1 payment
|
| Endo Pharmaceuticals | Aveed | $55 | 3 payments
|
| Boston Scientific | Wolverine Coronary Cutting Balloon | $49 | 2 payments
|
| Astellas Pharma US | Xtandi | $43 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $28 | 1 payment
|
| Ethicon US | Megadyne | $25 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $23 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $21 | 1 payment
|
| Janssen Biotech | Erleada | $21 | 1 payment
|
| Medtronic | Interstim | $20 | 1 payment
|
| UroGen Pharma | Jelmyto | $15 | 1 payment
|
2022: $963
| Coloplast | Titan | $624 | 7 payments
|
| Antares Pharma | Nocdurna | $117 | 4 payments
|
| Boston Scientific | Emblem Mri S-Icd | $85 | 3 payments
|
| Abbott Laboratories | Vantageview | $43 | 2 payments
|
| Astellas Pharma US | Xtandi | $38 | 1 payment
|
| Abiomed | Impella | $35 | 1 payment
|
| Hollister | Infyna Chic | $22 | 1 payment
|
2021: $288
| Coloplast | Genesis | $182 | 2 payments
|
| Abbott Laboratories | Mitraclip System | $54 | 3 payments
|
| Boston Scientific | Emblem | $38 | 1 payment
|
| AngioDynamics | Smart Port Ct | $15 | 1 payment
|
Professional record
- NPI
- 1659318780
- Licence
- CA PA17909
- Trained
- Stanford University School of Medicine, 2004
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-05-31
- NPI last updated
- 2012-10-04
This is when the NPI record was last certified, not a medical board exam.